Copertina

PANX2 Suppresses Lung Adenocarcinoma Progression by Inducing Disulfidptosis and Enhancing Antitumor Immunity

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yi Chen, Zhao‐Yu Liu, Gao‐Wen Qu, Run‐Hao Zeng, Wen‐Xia Yao, Yong‐Bing Zhou, Xue Liang, Yu‐Xiong Lai
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Advanced Science
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation‐Induced Tumor Relapse by Reprogramming Antitumor Immunity
di: Duo Wang, et al.
Pubblicazione: (2025)

Bacterial Foreignization Nanosystem Elicits Multi-Phenotypic T Cells for Antitumor Immunity.
di: Zhuang, Wan-Ru, et al.
Pubblicazione: (2025)

Bacterial Foreignization Nanosystem Elicits Multi‐Phenotypic T Cells for Antitumor Immunity
di: Wan‐Ru Zhuang, et al.
Pubblicazione: (2025)

Recent Progress of Epigenetic Reprogramming Biomedicine to Activate Immunotherapeutic Antitumor Effects
di: Chu‐Yu Huang, et al.
Pubblicazione: (2025)

Albumin‐Bound STING Agonist Reprograms HSPCs to Antitumor Neutrophils Enhancing CD8 + T Cell Immunity
di: Jinsong Tao, et al.
Pubblicazione: (2026)

ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity
di: Xiao‐Jing Ding, et al.
Pubblicazione: (2025)

BZW1 Drives Immune Evasion in Lung Adenocarcinoma via Ferroptosis Suppression
di: Linyao Zhao, et al.
Pubblicazione: (2026)

Intrinsic PDL1 Signaling Modulates TGFBI‐Mediated Growth Suppression in Lung Adenocarcinoma
di: Thi Thanh Nha Nguyen, et al.
Pubblicazione: (2025)

Unlocking the Potential of Disulfidptosis‐Related LncRNAs in Lung Adenocarcinoma: A Promising Prognostic LncRNA Model for Survival and Immunotherapy Prediction
di: Xin Nie, et al.
Pubblicazione: (2024)

Mobilizing STING Pathway via a Cationic Liposome to Enhance Doxorubicin‐Induced Antitumor Immunity
di: Xiaochen Liu, et al.
Pubblicazione: (2024)

Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR
di: Yiran Fang, et al.
Pubblicazione: (2025)

Extracellular Matrix‐Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity
di: Yao Wu, et al.
Pubblicazione: (2024)

A tumor Microenvironment‐Derived Prognostic Model Guides IL‐27 as a Therapeutic Strategy to Restore T Cell Immunity in Lung Adenocarcinoma
di: Gaopu Xie, et al.
Pubblicazione: (2026)

HROB Induces Lung Adenocarcinoma Progression via ZC3HC1‐CCNB1 Axis Regulation and Cell Cycle Dysregulation
di: Zhe Zhang, et al.
Pubblicazione: (2025)

Elesclomol‐Induced Copper Influx Attenuates Lung Adenocarcinoma Progression With Involvement of the ER Stress/PCK2 Axis
di: Jian Zhao, et al.
Pubblicazione: (2025)

DPP7 Promotes Colorectal Cancer Progression Through GPX4‐Dependent Suppression of Disulfidptosis and Immune Evasion
di: Ruibing Li, et al.
Pubblicazione: (2025)

Non‐stoichiometric Sodium Chloride Reprograms Ionic Homeostasis to Enhance Antitumor Immunity
di: Chongxiao Wang, et al.
Pubblicazione: (2025)

Viral‐Directed Augmentation of Kupffer Cell Cross‐Presentation Provokes Antitumor Immunity Against Liver Metastasis
di: Chen Chen, et al.
Pubblicazione: (2025)

The Novel Fusion Protein Melittin‐MIL‐2 Exhibits Strong Antitumor Immune Effect in Lung Adenocarcinoma Cell A549
di: Weize Gao, et al.
Pubblicazione: (2024)

Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With TROP2 ‐ CAR ‐T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma
di: Yanyun Zhao, et al.
Pubblicazione: (2026)

Activation of HTR2B Suppresses Osteosarcoma Progression through the STAT1‐NLRP3 Inflammasome Pathway and Promotes OASL1+ Macrophage Production to Enhance Antitumor Immunity
di: Zhen Huang, et al.
Pubblicazione: (2025)

Cuproptosis and Mitophagy Mediated by the THUMPD1/IGF2R‐Dependent Suppression of AKT and Activation of AMPK Signaling Suppress Lung Adenocarcinoma Progression
di: Kai Wu, et al.
Pubblicazione: (2026)

Stimuli‐Responsive Nanoplatform for Photodynamic Therapy and Disulfidptosis Synergy
di: Feng Liu, et al.
Pubblicazione: (2026)

Intercellular Mitochondrial Transfer Enhances the Antitumor Immunity of CD8+ T Cells
di: Ce Guo, et al.
Pubblicazione: (2025)

Molecular dynamics simulation of PANX1 channel with/without mefloquine
di: Ruan, Zheng, et al.
Pubblicazione: (2025)

TFAP2A Promotes Cell Progression and Suppresses Ferroptosis in Lung Adenocarcinoma via Activating Transcription of CST1
di: Xinyu Luan, et al.
Pubblicazione: (2024)

Lactate Dehydrogenase A and a Novel Four‐Gene Signature as Dual Diagnostic Markers for Lung Adenocarcinoma and Ischemic Stroke
di: Jin Xie, et al.
Pubblicazione: (2026)

Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
di: Nanzhi Luo, et al.
Pubblicazione: (2025)

Radiogenomics in Leptomeningeal Metastasis of Lung Adenocarcinoma: MRI Patterns and Survival Outcomes Following Ommaya Reservoir Chemotherapy
di: Yi‐zhen Jia, et al.
Pubblicazione: (2026)

A Mechanical Immune Checkpoint Inhibitor Stiffens Tumor Cells to Potentiate Antitumor Immunity
di: Yu Zhao, et al.
Pubblicazione: (2024)

A Mechanical Immune Checkpoint Inhibitor Stiffens Tumor Cells to Potentiate Antitumor Immunity
di: Yu Zhao, et al.
Pubblicazione: (2024)

Synergistic Calcium Overload and Hydrogen Release Potentiate Robust Antitumor Immunity
di: Xueqi Liang, et al.
Pubblicazione: (2026)

Biomimetic Nanomedicine Aligns Oxygen‐Sparing Metabolism With Light‐Triggered Therapy for Enhanced Antitumor Efficacy
di: Tong‐Yin Xiong, et al.
Pubblicazione: (2026)

Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs
di: Xizhi Yu, et al.
Pubblicazione: (2025)

PGK1 Suppresses CD8 + T Cell‐Mediated Antitumor Immunity Through CCL2/CCR2/Tumor‐Associated Macrophages Axis in Hepatocellular Carcinoma
di: Xi Liu, et al.
Pubblicazione: (2026)

Correction to “Engineering Multienzyme‐Mimicking Covalent Organic Frameworks as Pyroptosis Inducers for Boosting Antitumor Immunity”
di: Liang Zhang, et al.
Pubblicazione: (2024)

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
di: Mao, Churu, et al.
Pubblicazione: (2024)

Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
di: Ze‐Bo Jiang, et al.
Pubblicazione: (2025)

AML‐Targeted Metal‐Polyphenol Nanoplatform Induces Ferroptosis‐ICD Cascade for Antitumor Immunity Boosting
di: Shangqin Yang, et al.
Pubblicazione: (2026)

PC4 Potentially Predicts Chemoradiation‐Induced Antitumor Immunity in Esophageal Squamous Cell Carcinoma
di: Jieyong Tian, et al.
Pubblicazione: (2025)